Normal view
-
Molecular Therapy Advances
-
Management of acute infusion-related reactions in AAV gene therapy guided by mechanistic insight
Infusion-related reactions (IRRs) can occur with AAV gene therapy. IRRs were observed in two participants who received AAV8 gene therapy and in one who received AAV9 gene therapy. AAV gene therapy IRRs may be rate-related, possibly driven by complement activation. In our studies, a slow, staged infusion mitigated additional IRRs.
-
Molecular Therapy Nucleic Acids
-
Integrated in vitro transcription and oligo-dT affinity chromatography enable multi-cycle reagent recycling for mRNA manufacturing
Kis and colleagues report an integrated sequential-batch IVT–oligo-dT process that links RNA synthesis and affinity capture through a shared buffer, enabling direct crude-IVT loading and flowthrough recycling. The workflow improves cap-analog utilization and raw-material efficiency while preserving functional mRNA expression across five cycles.
Integrated in vitro transcription and oligo-dT affinity chromatography enable multi-cycle reagent recycling for mRNA manufacturing
-
Molecular Therapy Nucleic Acids
-
An mRNA–lipid nanoparticle vaccine targeting the Plasmodium vivax E140 antigen
Immunization with a nucleoside-modified mRNA-LNP vaccine encoding the conserved malaria antigen E140 induced durable humoral immunity in mice and generated invasion-blocking antibodies against Plasmodium vivax. The results highlight E140 as a promising candidate for next-generation malaria vaccines.
An mRNA–lipid nanoparticle vaccine targeting the Plasmodium vivax E140 antigen
-
Molecular Therapy Nucleic Acids
-
Functional analysis of TTN uORFs reveals context-dependent translational regulation
TTN truncating variants cause dilated cardiomyopathy and may be amenable to therapeutic upregulation. Disrupting TTN upstream open reading frames (uORFs) increased luciferase reporter expression, however disrupting endogenous uORFs in hiPSC-derived cardiomyocytes did not increase titin protein. This highlights the importance of validating regulatory mechanisms in disease-relevant cellular contexts.
Functional analysis of TTN uORFs reveals context-dependent translational regulation
-
Molecular Therapy Nucleic Acids
-
Novel lipid nanoparticle in a mRNA cancer vaccine drives tumor control via type I IFNs and effector CD8+ T cells
Ionizable lipid components of LNP vaccine formulations play an integral role in providing the necessary immune stimulatory signals required for effective anti-tumor T cell responses. This study finds that inclusion of a novel ionizable lipid confers effective tumor control in part through the generation of type I interferons.
Novel lipid nanoparticle in a mRNA cancer vaccine drives tumor control via type I IFNs and effector CD8+ T cells
-
Molecular Therapy
-
BRD4 Inhibition Mitigates Acute and Chronic Corneal Injury Following Topical Nitrogen Mustard Exposure
Lu and colleagues identify BRD4 as a central epigenetic driver of vesicant-induced corneal injury. Using reproducible mouse and rabbit models, they show that short-term topical BRD4 inhibition suppresses acute inflammation and provides durable protection of corneal clarity, stromal organization, endothelial integrity, and neovascularization, supporting translational therapy for chemical eye injuries.
BRD4 Inhibition Mitigates Acute and Chronic Corneal Injury Following Topical Nitrogen Mustard Exposure
-
Molecular Therapy
-
Targeting of the oncogenic fusion EWSR1-FLI1 in Ewing Sarcoma by CRISPR/dCas9 silencers
Blancafort and colleagues describe a non-viral polymeric system for the delivery of dCas9-KRAB silencers as ribonucleoprotein (RNP) payloads for EWSR1-FLI1 repression. They demonstrate highly efficient RNP delivery and robust silencing of EWSR1-FLI1 in both cell line and patient-derived xenografts of Ewing sarcoma, accompanied by potent anti-tumor effects.
Targeting of the oncogenic fusion EWSR1-FLI1 in Ewing Sarcoma by CRISPR/dCas9 silencers
-
Molecular Therapy
-
A renewed role for DNA vaccines for tuberculosis
Tuberculosis (TB) remains a leading cause of infection-related mortality worldwide, with an estimated 10.7 million incident cases and 1.23 million deaths recorded in 2024.1 The Bacillus Calmette-Guérin vaccine (BCG), despite over a century of use, provides unreliable protection against pulmonary disease in adolescents and adults, and the identification of antigens capable of inducing durable protective immunity in these populations remains an unsolved challenge. Against this backdrop, the emerge
A renewed role for DNA vaccines for tuberculosis
-
Molecular Therapy
-
In vivo engineering of T cells with a synthetic cytokine receptor enables selective enrichment and expansion of anti-CD22 CAR T cells
In preclinical studies, UB-VV400, an off-the-shelf, investigational lentiviral drug product, generates fully human anti-CD22 CAR T cells in vivo without the need for lymphodepletion. Activation of the synthetic rapamycin-activated cytokine receptor drives selective CAR T cell expansion and enrichment, resulting in complete tumor clearance and B cell depletion.
In vivo engineering of T cells with a synthetic cytokine receptor enables selective enrichment and expansion of anti-CD22 CAR T cells
-
Molecular Therapy
-
A modified cyclosporine enhances lentivector transduction ex vivo and in vivo by degrading IFITM3
Cellular antiviral defenses limit lentivector gene delivery. The authors describe lentivector transduction enhancement via inhibition of antiviral IFITM3 by novel inhibitor BG147. BG147 has activity ex vivo in human stem cells and in vivo in mouse subretinal cells, driving IFITM3 degradation via lysosomes. BG147 can expand lentivector utility and reduce treatment costs.
A modified cyclosporine enhances lentivector transduction ex vivo and in vivo by degrading IFITM3
-
Molecular Therapy
-
Capless self-amplifying mRNA vaccine induces dose-sparing protective immunity against HPAI clade 2.3.4.4 H5 virus in mice
Song and colleagues report an enterovirus-derived capless self-amplifying mRNA vaccine platform that uses internal ribosome entry site-mediated translation to eliminate 5′ capping. When encoding H5 hemagglutinin, CLsamRNA induces robust humoral and cellular immunity and dose-sparing protection against lethal H5N8 challenge in mice, supporting a distinct RNA vaccine architecture.
Capless self-amplifying mRNA vaccine induces dose-sparing protective immunity against HPAI clade 2.3.4.4 H5 virus in mice
-
Molecular Therapy
-
Injectable bioinstructive microfoam for rapid bedside/in vivo programming of CAR-T cells
Injectable methylcellulose microfoam enables rapid bedside/in vivo generation of CAR-T cells by colocalizing patient PBMCs, gene therapy vectors, and stimulatory cues. The platform enhances gene transfer, minimizes systemic vector exposure, and produces therapeutically effective CAR-T cells without conventional ex vivo manufacturing, potentially expanding patient access to cellular immunotherapy.
Injectable bioinstructive microfoam for rapid bedside/in vivo programming of CAR-T cells
-
Molecular Therapy
-
A singular base-editing platform for polyfunctional multiplex engineering of immune cells
This article demonstrates the use of adenine base editor nickase activity for precise transgene cargo integration while simultaneously carrying out multiplex gene knockout. This single-step platform achieves efficient knockin and >90% quadplex gene knockout without detectable translocations and low levels of off-target editing, producing highly functional, customizable chimeric antigen receptor T cells.
A singular base-editing platform for polyfunctional multiplex engineering of immune cells
-
Molecular Therapy
-
Multivalent DNA vaccines induce potent cellular responses and prolong BCG-mediated control of Mycobacterium tuberculosis
Multivalent DNA plasmids, each encoding a diverse set of Mtb antigens, elicited robust polyfunctional T cell responses in naive and BCG-primed mice. Boosting with the lead construct, pESX, resulted in superior immunogenicity that correlated with prolonged pulmonary bacterial control in BCG-primed mice.
Multivalent DNA vaccines induce potent cellular responses and prolong BCG-mediated control of Mycobacterium tuberculosis
-
cs.AI, q-bio.NC updates on arXiv.org
-
XAI-Refine: An Automated Explanation-Knowledge Loop for Brain-Age Prediction
arXiv:2609.09388v1 Announce Type: cross Abstract: Brain-age prediction models are commonly evaluated by predictive accuracy, yet accurate predictions alone do not establish that a model relies on reproducible or neurobiologically supported mechanisms. Post-hoc explanation methods can expose these mechanisms, but existing workflows typically stop at diagnosis or require correction targets to be specified before model analysis. We propose XAI-Refine, an automated explanation-knowledge loop for br
XAI-Refine: An Automated Explanation-Knowledge Loop for Brain-Age Prediction
-
cs.AI, q-bio.NC updates on arXiv.org
-
Teacher Geometry Shapes Learnability in Teacher-Student Networks
arXiv:2609.09595v1 Announce Type: cross Abstract: Teacher-student systems, in which a teacher neural network generates training labels so that a student neural network can learn to implement the same function, are widely used as an abstract setting to study learning. However, the structure of the teachers is often overlooked by assuming randomly-generated, normally-distributed parameters. This hides substantial variation in how learnable different teachers are. We formalize learnability as the
Teacher Geometry Shapes Learnability in Teacher-Student Networks
-
cs.AI, q-bio.NC updates on arXiv.org
-
Emergency Department Revisit Quality Review Screening: Exploring Human Decision-Making and Artificial Intelligence Support
arXiv:2609.10421v1 Announce Type: cross Abstract: Background: Emergency Department (ED) return visits are commonly reviewed for quality assurance, but are often limited (e.g., to revisits within 48-72 hours) to increase actionable finding yield while minimizing chart review burden. Those limitations may lead to missed quality improvement opportunities. Methods: We conducted an exploratory, retrospective study of randomly selected ED visits to a multihospital health system having an ED revisit
Emergency Department Revisit Quality Review Screening: Exploring Human Decision-Making and Artificial Intelligence Support
-
STAT

-
Opinion: Autonomous AI will beat AI-assisted physicians at some medical tasks by 2030
Ezekiel J. Emanuel and Abe Baker-Butler have been debating the proper place for AI in medicine with American Medical Association CEO John Whyte. Now, they are taking their discussion to STAT’s First Opinion. Read Emanuel and Baker-Butler’s essay below and read Whyte’s essay here. In 1867, Joseph Lister published his research on carbolic acid and antiseptic surgical technique. In September 1871, he was summoned to Queen Victoria, who had a rapidly growing abscess in her left armpit. Using his
Opinion: Autonomous AI will beat AI-assisted physicians at some medical tasks by 2030
Ezekiel J. Emanuel and Abe Baker-Butler have been debating the proper place for AI in medicine with American Medical Association CEO John Whyte. Now, they are taking their discussion to STAT’s First Opinion. Read Emanuel and Baker-Butler’s essay below and read Whyte’s essay here.
In 1867, Joseph Lister published his research on carbolic acid and antiseptic surgical technique. In September 1871, he was summoned to Queen Victoria, who had a rapidly growing abscess in her left armpit. Using his antiseptic surgical technique, Joseph Lister successfully drained the pus. Queen Victoria recovered without fever or other complications. The antiseptic technique quickly gained approval in the U.K. and Europe, but not among American physicians.


© Adobe
-
Nature - Issue - nature.com science feeds
-
PLA2G2D in tumour-draining lymph nodes regulates anti-tumour immunity
Nature, Published online: 09 September 2026; doi:10.1038/s41586-026-10954-1A specific population of macrophages that express high levels of the enzyme PLA2G2D in tumour-draining lymph nodes is associated with poor prognosis in patients, and inhibiting PLA2G2D improves anti-tumour immunity in mouse models.
PLA2G2D in tumour-draining lymph nodes regulates anti-tumour immunity
Nature, Published online: 09 September 2026; doi:10.1038/s41586-026-10954-1
A specific population of macrophages that express high levels of the enzyme PLA2G2D in tumour-draining lymph nodes is associated with poor prognosis in patients, and inhibiting PLA2G2D improves anti-tumour immunity in mouse models.-
Nature - Issue - nature.com science feeds
-
Imaging cellular activity across all organs reveals body-wide circuits
Nature, Published online: 09 September 2026; doi:10.1038/s41586-026-10979-6An imaging system developed to record cellular activity throughout the whole body of zebrafish captures cellular organ dynamics and identifies multiple distributed circuits.
Imaging cellular activity across all organs reveals body-wide circuits
Nature, Published online: 09 September 2026; doi:10.1038/s41586-026-10979-6
An imaging system developed to record cellular activity throughout the whole body of zebrafish captures cellular organ dynamics and identifies multiple distributed circuits.